Location History:
- Eppstein, DE (1987)
- Eppstein/Taunus, DE (1995)
Company Filing History:
Years Active: 1987-1995
Title: Waldemar Wetekam: Innovator in Polypeptide Synthesis
Introduction
Waldemar Wetekam is a notable inventor based in Eppstein/Taunus, Germany. He has made significant contributions to the field of biotechnology, particularly in the synthesis of polypeptides. With a total of 2 patents, Wetekam's work has advanced the understanding and application of genetic engineering methods.
Latest Patents
Wetekam's latest patents include innovative methods for the preparation of polypeptides with specific terminal ends. One of his patents focuses on the preparation of polypeptides having an amide carboxyl terminal end. This involves synthesizing a polypeptide with a glycine residue at the C terminal end and converting it enzymatically into the desired carboxamide group. This method allows for the creation of peptides that have the amino acid sequence of growth hormone-releasing factor and its modifications.
Another significant patent is for the preparation of secretin, which cannot be directly synthesized due to its carboxylic acid carboxyl-terminus. Wetekam's approach involves preparing secretylglycine through genetic engineering and then enzymatically converting it into secretin. This process highlights the innovative use of chemical synthesis and enzymatic conversion in peptide production.
Career Highlights
Throughout his career, Wetekam has worked with prominent companies, including Hoechst Aktiengesellschaft. His experience in these organizations has contributed to his expertise in biotechnology and polypeptide synthesis.
Collaborations
Wetekam has collaborated with notable professionals in his field, including Wolfgang Konig and Joachim Engels. These collaborations have likely enriched his research and development efforts.
Conclusion
Waldemar Wetekam's contributions to the field of biotechnology, particularly in polypeptide synthesis, demonstrate his innovative spirit and dedication to advancing scientific knowledge. His patents reflect a deep understanding of genetic engineering and its applications in peptide production.